Biologics in Severe Allergic Asthma

Speciality: Pulmonary Medicine

Description:

A warm welcome to all the medical professionals in this interesting session on biologics target severe allergic asthma, improving lung function and reducing exacerbations.

Biologics are a breakthrough in treating severe allergic asthma, targeting specific immune pathways to reduce inflammation and improve symptoms. In individuals with severe asthma not well-controlled by standard medications, biologics offer a targeted approach, often by blocking key inflammatory molecules like interleukins or immunoglobulin E (IgE). These medications, typically monoclonal antibodies, help reduce asthma exacerbations, improve lung function, and enhance quality of life.

Biologics are especially effective in eosinophilic asthma subtypes, where elevated eosinophil levels indicate a more robust inflammatory response. Treatment selection is guided by patient-specific factors like biomarker profiles and treatment response. While biologics have revolutionized asthma management, their high cost and route of administration (usually via injection or infusion) are important considerations.

However, for individuals with severe allergic asthma unresponsive to traditional therapies, biologics offer hope for better symptom control and improved quality of life.

Therefore, get an overall knowledge on biologics target severe allergic asthma, improving lung function and reducing exacerbations.

See More Webinars @ Hidoc Webinars